共 50 条
- [21] LOW-DOSE ARA-C AS AN ALTERNATIVE THERAPY FOR OLDER PATIENTS WITH AML BLUT, 1985, 51 (03): : 163 - 163
- [22] Reversal of cytosine arabinoside (ara-C) resistance by the synergistic combination of 6-thioguanine plus ara-C plus PEG-asparaginase (TGAP) in human leukemia lines lacking or expressing p53 protein Cancer Chemotherapy and Pharmacology, 2001, 48 : 123 - 133
- [26] Ara-CTP-SNP-Score (ACSS) Created from SNP within the Cytarabine Metabolic Pathway Correlates with Response to Ara-C Induction Therapy in Elderly Patients with AML: A Pilot Study CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S201 - S201
- [30] PROLONGED SURVIVAL OF PATIENTS WITH ACUTE NON-LYMPHOBLASTIC LEUKEMIA FOLLOWING ARABINOSYL CYTOSINE (ARA-C), VINCRISTINE (VCR) AND PREDNISONE (PRED) INDUCTION AND ARA-C MAINTENANCE THERAPY PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1973, 14 (MAR): : 91 - +